The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palliser, D.
Right arrow Articles by Eisen, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palliser, D.
Right arrow Articles by Eisen, H. N.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2005, 174: 1879-1887.
Copyright © 2005 by The American Association of Immunologists

Multiple Intracellular Routes in the Cross-Presentation of a Soluble Protein by Murine Dendritic Cells1

Deborah Palliser2,3,*, Eduardo Guillen2,*,{dagger}, Mindy Ju* and Herman N. Eisen4,*

* Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and {dagger} Stressgen Biotechnologies, San Diego, CA 92121

Soluble heat shock fusion proteins (Hsfp) stimulate mice to produce CD8+ CTL, indicating that these proteins are cross-presented by dendritic cells (DC) to naive CD8 T cells. We report that cross-presentation of these proteins depends upon their binding to DC receptors, likely belonging to the scavenger receptor superfamily. Hsfp entered DC by receptor-mediated endocytosis that was either inhibitable by cytochalasin D or not inhibitable, depending upon aggregation state and time. Most endocytosed Hsfp was transported to lysosomes, but not the small cross-presented fraction that exited early from the endocytic pathway and required access to proteasomes and TAP. Naive CD8 T cell (2C and OT-I) responses to DC incubated with Hsfp at 1 µM were matched by incubating DC with cognate octapeptides at 1–10 pM, indicating that display of very few class I MHC-peptide complexes per DC can be sufficient for cross-presentation. With an Hsfp (heat shock protein-OVA) having peptide sequences for both CD4+ (OT-II) and CD8+ (OT-I) cells, the CD4 cells responded far more vigorously than the CD8 cells and many more class II MHC-peptide than class I MHC-peptide complexes were displayed.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. W. Howland and K. D. Wittrup
Antigen Release Kinetics in the Phagosome Are Critical to Cross-Presentation Efficiency
J. Immunol., February 1, 2008; 180(3): 1576 - 1583.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Sun, A.-E. Deghmane, H. Soualhine, T. Hong, C. Bucci, A. Solodkin, and Z. Hmama
Mycobacterium bovis BCG disrupts the interaction of Rab7 with RILP contributing to inhibition of phagosome maturation
J. Leukoc. Biol., December 1, 2007; 82(6): 1437 - 1445.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Bendz, S. C. Ruhland, M. J. Pandya, O. Hainzl, S. Riegelsberger, C. Brauchle, M. P. Mayer, J. Buchner, R. D. Issels, and E. Noessner
Human Heat Shock Protein 70 Enhances Tumor Antigen Presentation through Complex Formation and Intracellular Antigen Delivery without Innate Immune Signaling
J. Biol. Chem., October 26, 2007; 282(43): 31688 - 31702.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Tsuda, D. Z. Chang, T. Mine, C. Efferson, A. Garcia-Sastre, X. Wang, S. Ferrone, and C. G. Ioannides
Taxol Increases the Amount and T Cell Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells
Cancer Res., September 1, 2007; 67(17): 8378 - 8387.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. G ROUTSIAS and A. G TZIOUFAS
The Role of Chaperone Proteins in Autoimmunity
Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 52 - 64.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.